Holen Sie sich die Stockscreener-App
2.28
8.57%
0.18
Handel nachbörslich:
2.30
0.02
+0.88%
Schlusskurs vom Vortag:
$2.10
Offen:
$2.12
24-Stunden-Volumen:
4.74M
Relative Volume:
1.83
Marktkapitalisierung:
$376.00M
Einnahmen:
$101.21M
Nettoeinkommen (Verlust:
$-569.00K
KGV:
-114.00
EPS:
-0.02
Netto-Cashflow:
$-56.88M
1W Leistung:
+11.76%
1M Leistung:
-3.80%
6M Leistung:
+270.61%
1J Leistung:
+93.22%
1-Tages-Spanne:
$2.07
$2.29
1-Wochen-Bereich:
$2.00
$2.29
52-Wochen-Spanne:
$0.40
$3.095
Cytomx Therapeutics Inc Stock (CTMX) Company Profile
Firmenname
Cytomx Therapeutics Inc
Sektor
Branche
Telefon
650.515.3185
Adresse
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie CTMX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTMX
Cytomx Therapeutics Inc
|
2.28 | 346.32M | 101.21M | -569.00K | -56.88M | -0.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2025-05-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-04-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-05-28 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-05-09 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-05-06 | Hochstufung | Jefferies | Hold → Buy |
| 2024-04-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-11-14 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-07-07 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-07-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-07-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-06-24 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-01-18 | Hochstufung | Barclays | Underweight → Overweight |
| 2021-11-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-28 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-03-29 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-23 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-06-01 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-24 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-03-04 | Eingeleitet | Barclays | Equal Weight |
| 2019-11-20 | Eingeleitet | Guggenheim | Buy |
| 2019-11-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-06-13 | Eingeleitet | Mizuho | Buy |
| 2019-05-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-03-11 | Eingeleitet | Barclays | Overweight |
| 2018-11-26 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-10-15 | Eingeleitet | Goldman | Neutral |
| 2018-09-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-06-01 | Eingeleitet | SunTrust | Buy |
| 2018-01-05 | Eingeleitet | Citigroup | Buy |
| 2017-09-08 | Eingeleitet | Wedbush | Outperform |
| 2017-03-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2017-01-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2015-11-02 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Cytomx Therapeutics Inc Aktie (CTMX) Neueste Nachrichten
CytomX Therapeutics Inc.’s volatility index tracking explained2025 Top Decliners & Safe Capital Growth Tips - Newser
How to recover losses in CytomX Therapeutics Inc. stockWeekly Trend Summary & Verified Momentum Stock Ideas - Newser
CytomX Therapeutics Inc. Building a Base Near Support2025 Buyback Activity & Entry Point Strategy Guides - beatles.ru
Is CytomX Therapeutics Inc. forming higher highs and higher lowsBear Alert & Short-Term Swing Trade Alerts - خودرو بانک
Will CytomX Therapeutics Inc. benefit from AI trendsPortfolio Risk Summary & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Can CytomX Therapeutics Inc. maintain sales growthJuly 2025 Market Mood & Technical Buy Zone Confirmation - خودرو بانک
Identifying reversal signals in CytomX Therapeutics Inc.2025 Historical Comparison & Risk Controlled Daily Plans - Newser
News impact scoring models applied to CytomX Therapeutics Inc.July 2025 Spike Watch & Expert Approved Momentum Trade Ideas - Newser
How to forecast CytomX Therapeutics Inc. trends using time seriesJuly 2025 Gainers & Community Supported Trade Ideas - Newser
Should you hold or exit CytomX Therapeutics Inc. nowTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
Historical volatility pattern of CytomX Therapeutics Inc. visualizedMarket Growth Summary & Free High Accuracy Swing Entry Alerts - Newser
Statistical indicators supporting CytomX Therapeutics Inc.’s strengthWeekly Loss Report & Consistent Return Strategy Ideas - Newser
Can you recover from losses in CytomX Therapeutics Inc.Market Movement Recap & Fast Entry Momentum Alerts - Newser
Is CytomX Therapeutics Inc. vulnerable to short sellersQuarterly Investment Review & Safe Capital Allocation Plans - خودرو بانک
Sentiment analysis tools applied to CytomX Therapeutics Inc.Quarterly Portfolio Report & Consistent Return Strategy Ideas - Newser
CytomX Therapeutics Inc. stock trend forecast2025 Macro Impact & AI Forecasted Stock Moves - Newser
Will CytomX Therapeutics Inc. stock recover after recent dropInsider Selling & Weekly Chart Analysis and Guides - Newser
Real time social sentiment graph for CytomX Therapeutics Inc.July 2025 Movers & High Accuracy Swing Entry Alerts - Newser
Technical analysis overview for CytomX Therapeutics Inc. stock2025 Bull vs Bear & Momentum Based Trading Signals - Newser
Is CytomX Therapeutics Inc. stock bottoming outJuly 2025 Trends & Fast Gaining Stock Strategy Reports - Newser
What institutional flow reveals about CytomX Therapeutics Inc.Market Performance Recap & Real-Time Sentiment Analysis - Newser
Is CytomX Therapeutics Inc. showing signs of accumulationJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Will CytomX Therapeutics Inc. benefit from macro trends2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
CytomX Therapeutics Inc. stock trendline breakdownJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Leading vs lagging indicators on CytomX Therapeutics Inc. performanceMarket Growth Review & Accurate Technical Buy Alerts - Newser
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2025 Earnings Call Transcript - MSN
Published on: 2025-09-03 09:30:47 - Newser
What earnings revisions data tells us about CytomX Therapeutics Inc.Weekly Stock Recap & Long-Term Growth Plans - Newser
Published on: 2025-09-03 13:30:24 - beatles.ru
What earnings revisions data tells us about CytomX Therapeutics IncJuly 2025 Levels & Weekly Momentum Stock Picks - Newser
Is CytomX Therapeutics Inc. benefiting from innovation trendsJuly 2025 Drop Watch & Fast Entry High Yield Tips - خودرو بانک
Will Windtree Therapeutics Inc. outperform during market ralliesJuly 2025 Short Interest & Fast Moving Trade Plans - خودرو بانک
Market Outlook: Will CytomX Therapeutics Inc. benefit from AI trendsJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Is CytomX Therapeutics Inc. trading at a discountJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - خودرو بانک
Will CytomX Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Safe Entry Trade Signal Reports - Newser
Does CytomX Therapeutics Inc. meet Warren Buffett’s criteriaJuly 2025 Momentum & Long-Term Growth Portfolio Plans - خودرو بانک
Finanzdaten der Cytomx Therapeutics Inc-Aktie (CTMX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):